BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11914663)

  • 61. Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism.
    Pham TH; Sterioff S; Mullan BP; Wiseman GA; Sebo TJ; Grant CS
    World J Surg; 2006 Mar; 30(3):327-32. PubMed ID: 16470331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [(99m)Tc]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations.
    Olaizola I; Zingraff J; Heuguerot C; Fajardo L; Léger A; Lopez J; Acuña G; Petraglia A; Alvarez A; Caorsi H; Drüeke T; Ambrosoni P
    Nephrol Dial Transplant; 2000 Aug; 15(8):1201-6. PubMed ID: 10910445
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
    Casas AT; Burke GJ; Mansberger AR; Wei JP
    Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal imaging time for delayed images in the diagnosis of abnormal parathyroid tissue with Tc-99m sestamibi.
    Jofré J; González P; Massardo T; Zavala A
    Clin Nucl Med; 1999 Aug; 24(8):594-6. PubMed ID: 10439181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ectopic parathyroid adenomas located at the carotid bifurcation: the role of preoperative Tc-99m MIBI scintigraphy and the intraoperative gamma probe procedure in surgical treatment planning.
    Rubello D; Piotto A; Pagetta C; Pelizzo M; Casara D
    Clin Nucl Med; 2001 Sep; 26(9):774-6. PubMed ID: 11507296
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parathyroid imaging with technetium-99m sestamibi.
    Fujii H; Kubo A
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():12s-16s. PubMed ID: 10914984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Minimally invasive radionuclide-guided parathyroidectomy using 99mTc-sestamibi in patients with primary hyperparathyroidism: a single-institution experience.
    Usmani S; Khan HA; al Mohannadi S; Javed A; al Nafisi N; abu Huda F; Tuli M; Amanguno HG; Abdulla MA; Al Khalidi K
    Med Princ Pract; 2009; 18(5):373-7. PubMed ID: 19648760
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
    Kebapci M; Entok E; Kebapci N; Adapinar B
    J Endocrinol Invest; 2004 Jan; 27(1):24-30. PubMed ID: 15053239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Fifteen years experience in the surgical treatment of primary hyperparathyroidism].
    Berczi C; Garai I; Horkay E; Galuska L; Balázs G; Lukács G
    Magy Seb; 2001 Dec; 54(6):351-5. PubMed ID: 11816131
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of pinhole and SPECT 99mTc-MIBI imaging in primary hyperparathyroidism.
    Ho Shon IA; Yan W; Roach PJ; Bernard EJ; Shields M; Sywak M; Sidhu S; Delbridge LW
    Nucl Med Commun; 2008 Nov; 29(11):949-55. PubMed ID: 18836372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Parathyroid imaging: preoperative localization.
    O'Doherty MJ; Kettle AG
    Nucl Med Commun; 2003 Feb; 24(2):125-31. PubMed ID: 12548036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The accuracy of 99m Tc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism.
    Saengsuda Y
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S81-91. PubMed ID: 22619892
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
    Wei JP; Burke GJ; Mansberger AR
    Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients.
    Jones JM; Russell CF; Ferguson WR; Laird JD
    Clin Radiol; 2001 Jul; 56(7):556-9. PubMed ID: 11446753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multiinstitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS).
    Rubello D; Pelizzo MR; Boni G; Schiavo R; Vaggelli L; Villa G; Sandrucci S; Piotto A; Manca G; Marini P; Mariani G
    J Nucl Med; 2005 Feb; 46(2):220-6. PubMed ID: 15695779
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [99m-Tc sestamibi scintigraphy in primary hyperparathyroidism. Importance of lateral projections using a pin-hole collimator].
    Serrano Vicente J; Rayo Madrid JI; Luengo Pérez LM; Díaz Pérez de Madrid J
    Rev Esp Med Nucl; 2003 Nov; 22(6):403-9. PubMed ID: 14588233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.
    Carlier T; Oudoux A; Mirallié E; Seret A; Daumy I; Leux C; Bodet-Milin C; Kraeber-Bodéré F; Ansquer C
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):637-43. PubMed ID: 17960377
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radionuclide parathyroid imaging: a concise, updated review.
    Moralidis E
    Hell J Nucl Med; 2013; 16(2):125-33. PubMed ID: 23687643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.